Stockscreener 앱 받기
40.16
1.03%
0.41
시간 외 거래:
40.16
전일 마감가:
$39.75
열려 있는:
$40.38
하루 거래량:
1.41M
Relative Volume:
1.23
시가총액:
$2.87B
수익:
-
순이익/손실:
$-299.62M
주가수익비율:
-8.6108
EPS:
-4.6639
순현금흐름:
$-241.73M
1주 성능:
+4.80%
1개월 성능:
-3.65%
6개월 성능:
+48.96%
1년 성능:
+49.02%
1일 변동 폭
$39.83
$41.55
1주일 범위
$37.51
$42.25
52주 변동 폭
$18.53
$56.05
베라 테라 Stock (VERA) Company Profile
명칭
Vera Therapeutics Inc
전화
650-770-0077
주소
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
40.16 | 2.84B | 0 | -299.62M | -241.73M | -4.6639 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
베라 테라 Stock (VERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-11 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-10-16 | 개시 | BofA Securities | Buy |
| 2025-08-04 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | 재개 | H.C. Wainwright | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2025-01-28 | 개시 | Goldman | Buy |
| 2024-11-21 | 개시 | Wells Fargo | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-25 | 개시 | Oppenheimer | Outperform |
| 2024-01-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-12-18 | 개시 | Raymond James | Outperform |
| 2023-11-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-16 | 개시 | Guggenheim | Buy |
| 2023-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-04 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-07-12 | 개시 | JP Morgan | Overweight |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2022-04-19 | 개시 | Wedbush | Outperform |
모두보기
베라 테라 주식(VERA)의 최신 뉴스
Calif. Biotech Firm Vera Taps Vaxcyte Ex-GC As New CLO - Law360
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer By Investing.com - Investing.com Canada
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer - Quiver Quantitative
Biotech nearing drug launch hires veteran lawyer as legal chief - Stock Titan
E. Ohman J or Asset Management AB Invests $2 Million in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock advances on promising Phase 3 data for atacicept in IgA nephropathy, boostin - AD HOC NEWS
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
(VERA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Investment Firm Boosts Vera Therapeutics Holding to $41.75M in 2026News and Statistics - IndexBox
This $91 Million Investment Reflects Strong Confidence in a Biotech Firm Awaiting an FDA Ruling This Year - Bitget
Hudson Bay Capital Management Boosts Stake in Vera Therapeutics - National Today
Hudson Bay Capital Management LP Raises Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Stock Is Suddenly Taking Off - TipRanks
Volume Summary: What is the next catalyst for Vera Therapeutics Inc2026 Top Decliners & Weekly Setup with High ROI Potential - baoquankhu1.vn
Deep Track Capital, LP Increases Stake in Vera Therapeutics Inc - GuruFocus
Algert Global LLC Acquires 39,235 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics (VERA) finance chief exercises options for 10,000 shares - Stock Titan
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment - AOL.com
Eversept Partners Increases Stake in Vera Therapeutics - Intellectia AI
Assessing Vera Therapeutics (VERA) Valuation As Deerfield Ups Stake And FDA Priority Review Nears - simplywall.st
HighVista Strategies LLC Increases Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics, Inc. $VERA Shares Sold by First Light Asset Management LLC - MarketBeat
Cinctive Capital Management LP Sells 65,510 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Braidwell LP Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Wall Street analysts see a 53.05% upside in Vera Therapeutics (VERA): Can the stock really move this high? - MSN
Integral Health Asset Management LLC Has $49.40 Million Stock Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Avoro Capital Advisors Reduces Stake in Vera Therapeutics - National Today
Avoro Capital Advisors LLC Sells 90,000 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - AOL.com
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - The Motley Fool
Vera Therapeutics, Inc. $VERA Holdings Raised by Schroder Investment Management Group - MarketBeat
Published on: 2026-03-13 13:04:33 - baoquankhu1.vn
Aug Big Picture: What is the cash position of Vera Therapeutics Inc2026 Price Action Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Vera Therapeutics urges expanded innovation in global kidney health on World Kidney Day - Traders Union
Wolfe Research upgrades Vera Therapeutics (VERA) - MSN
Quarterly Trades: Can Vera Therapeutics Inc deliver consistent EPS growth2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Deep Track files 13G disclosing 5.50% stake in Vera Therapeutics (NASDAQ: VERA) - Stock Titan
Vera Therapeutics (NASDAQ:VERA) Upgraded to Outperform at Wolfe Research - MarketBeat
How (VERA) Movements Inform Risk Allocation Models - Stock Traders Daily
Wolfe Research upgrades Vera Therapeutics stock rating on valuation By Investing.com - Investing.com Canada
Vera Therapeutics (NASDAQ:VERA) Trading Up 10.2%What's Next? - MarketBeat
Vera Therapeutics’ Atacicept Gains FDA Priority, Stock Soars - StocksToTrade
Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities - Investing.com Canada
Vera Therapeutics Adds Christopher Hite to Board - TipRanks
Vera Therapeutics appoints Christopher Hite to Board as Class III Director - TradingView
Director at Vera Therapeutics (VERA) receives grant of 24,937 stock options - Stock Titan
Director Christopher Hite files initial Form 3 at Vera Therapeutics (VERA) - Stock Titan
Vera Therapeutics Appoints New Board Member - Intellectia AI
Rhenman & Partners Asset Management AB Invests $3.78 Million in Vera Therapeutics, Inc. $VERA - MarketBeat
Can Vera Therapeutics Inc. stock deliver surprise earnings beat2026 EndofYear Setup & Weekly Return Optimization Plans - Naître et grandir
GW&K Investment Management LLC Reduces Stake in Vera Therapeutics, Inc. $VERA - MarketBeat
베라 테라 (VERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):